News and Events

NEOMED-LABS and Public Health England Announce a Strategic Agreement

June 27, 2019

Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are pleased to announce that they have entered into a strategic partnership to engage in the improvement of global human health. This partnership is focused on vaccine projects with the objective of jointly developing new pre-clinical … Continued

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

June 6, 2019

LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized in assay development and clinical laboratory testing for vaccines and soluble large molecules, announced today the acquisition of PAIRimmune, a non-GLP preclinical immunology service provider based in Laval, Quebec. With over 20 years of legacy … Continued

Meet NEOMED-LABS team at the World Vaccine Congress in Washington from April 14 to 17!

April 4, 2019

We will present during the Influenza and Respiratory Vaccines session and will welcome you at our booth # 422 to discuss immunology assay development and clinical sample testing. We look forward to seeing you there!   www.neomedlabs.com info@neomedlabs.com

Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers

March 28, 2019

LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service provider specialized in assay development and clinical laboratory testing for vaccines and soluble large molecules, announced today the appointment of Tim McGrath to the role of Chief Operating Officer. In his role, he will contribute … Continued